Amitriptylin 25 mg comprimate filmate Republica Moldova - română - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

amitriptylin 25 mg comprimate filmate

zentiva a.s. - amitriptylinum - comprimate filmate - 25 mg

Amitriptylin 25 mg comprimate filmate Republica Moldova - română - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

amitriptylin 25 mg comprimate filmate

zentiva a.s. - amitriptylinum - comprimate filmate - 25 mg

Hydrochlorothiazide 25 mg comprimate Republica Moldova - română - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

hydrochlorothiazide 25 mg comprimate

sandoz pharmaceuticals d.d. - hydrochlorothiazidum - comprimate - 25 mg

Vildagliptin / Metformin hydrochloride Accord Uniunea Europeană - română - EMA (European Medicines Agency)

vildagliptin / metformin hydrochloride accord

accord healthcare s.l.u. - metformin hydrochloride, vildagliptin - diabetul zaharat, tip 2 - medicamente utilizate în diabet - vildagliptin/metformin hydrochloride accord is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:- in patients who are inadequately controlled with metformin hydrochloride alone. - in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. - in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 și 5. 1 pentru datele disponibile pe diferite combinații).

Hypothiazid 100 mg comprimate Republica Moldova - română - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

hypothiazid 100 mg comprimate

chinoin pharmaceutical and chemical works private co. ltd - hydrochlorothiazidum - comprimate - 100 mg

Hypothiazid 25 mg comprimate Republica Moldova - română - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

hypothiazid 25 mg comprimate

chinoin pharmaceutical and chemical works private co. ltd - hydrochlorothiazidum - comprimate - 25 mg

CONVERIDE 150 mg/12,5 mg România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

converide 150 mg/12,5 mg

medochemie ltd-central factory - cipru - combinatii (irbersartanum+hydrochlorothiazidum) - compr. film. - 150mg/12,5mg - antagonisti ai angiotensinaei ii, combinatii antagonisti ai angiotensin ii si diuretic

CONVERIDE 300 mg/12,5 mg România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

converide 300 mg/12,5 mg

medochemie ltd-central factory - cipru - combinatii (irbersartanum+hydrochlorothiazidum) - compr. film. - 300mg/12,5mg - antagonisti ai angiotensinaei ii, combinatii antagonisti ai angiotensin ii si diuretic

CONVERIDE 300 mg/25 mg România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

converide 300 mg/25 mg

medochemie ltd-central factory - cipru - combinatii (irbersartanum+hydrochlorothiazidum) - compr. film. - 300mg/25mg - antagonisti ai angiotensinaei ii, combinatii antagonisti ai angiotensin ii si diuretic

Sitagliptin / Metformin hydrochloride Mylan Uniunea Europeană - română - EMA (European Medicines Agency)

sitagliptin / metformin hydrochloride mylan

mylan ireland limited - sitagliptin hydrochloride monohydrate, metformin hydrochloride - diabetul zaharat, tip 2 - medicamente utilizate în diabet - for adult patients with type 2 diabetes mellitus:sitagliptin/metformin hydrochloride mylan is indicated as an adjunct to diet and exercise to improve glycaemic control in patients inadequately controlled on their maximal tolerated dose of metformin alone or those already being treated with the combination of sitagliptin and metformin. sitagliptin/metformin hydrochloride mylan is indicated in combination with a sulphonylurea (i. , terapie triplă) ca adjuvant la dietă și exercițiu fizic, la pacienți controlați inadecvat cu doza maximă tolerată de metformin și o sulfoniluree. sitagliptin/metformin hydrochloride mylan is indicated as triple combination therapy with a peroxisome proliferator-activated receptor gamma (pparg) agonist (i. , a thiazolidinedione) as an adjunct to diet and exercise in patients inadequately controlled on their maximal tolerated dose of metformin and a pparg agonist. sitagliptin/metformin hydrochloride mylan is also indicated as add-on to insulin (i. , triple combination therapy) as an adjunct to diet and exercise to improve glycaemic control in patients when stable dose of insulin and metformin alone do not provide adequate glycaemic control.